-transparent.png){kind=logo}
Ten girls with Turner syndrome were treated with a combination therapy of recombinant human growth hormone (R-hGH) and low dose stanozolol for a period of 8 to 36 months. The results showed that when compared with the growth rate before the treatment, the growth rates after treatment with R-hGH and stanozolol showed a sustained increase, reaching 9.0 +/- 1.9 cm/year during the first year of treatment; the height age increase by 2.5 +/- 0.8 years while the bone age increase were 1.0 +/- 0.7 years; and the predicted final adult height at the end of the first year of the treatment increased to 149.4 +/- 6.1 cm compared to their original mean of 142.8 +/- 4.2 cm. We are led to conclude that therapy with R-hGH in combination with stanozolol can increase the growth velocity and significantly increase the predicted adult height of children with Turner syndrome.
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 2019,
BMC endocrine disorders,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 1992,
Hormone research,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 1990,
Birth defects original article series,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 1995,
The Southeast Asian journal of tropical medicine and public health,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 1989,
Hormone research,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
August 2015,
Clinical endocrinology,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
January 1993,
Hormone research,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
December 2008,
Therapeutics and clinical risk management,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
May 1988,
Tijdschrift voor kindergeneeskunde,
J Fang, and
C Ning, and
D Shu, and
H Wei, and
H Lin, and
M Wang
June 2015,
Pediatric endocrinology reviews : PER,
